Role of IL-16 in delayed-type hypersensitivity reaction

Blood

Volumn 95, Issue 9, 2000, Pages 2869-2874

  Yoshimoto, Takayuki ^a,b   Wang, Chrong Reen ^c   Yoneto, Toshihiko ^c   Matsuzawa, Akio ^c   Cruikshank, William W ^c   Nariuchi, Hideo ^c  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; FOOT PAD; IMMUNOPATHOGENESIS; LANGERHANS CELL; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034193126     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.9.2869.009k18_2869_2874     Document Type: Article

References (40)

1. Cruikshank WW, Center DM, Nisar N, et al. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci U S A. 1994;91:5109.
2. Center DM, Kornfeld H, Cruikshank WW. Interleukin 16 and its function as a CD4 ligand. Immunol Today. 1996;17:476.
3. Cruikshank WW, Lim K, Theodore AC, et al. IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol. 1996;157:5240.
4. Theodore AC, Center DM, Nicoll J, Fine G, Kornfeld H, Cruikshank WW. CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. J Immunol. 1996; 157:1958.
5. Baier M, Bannert N, Werner A, Lang K, Kurth R. Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci U S A. 1997;94:5273.
6. Keane J, Nicoll J, Kim S, et al. Conservation of structure and function between human and murine IL-16. J Immunol. 1998;160:5945.
7. Chupp GL, Wright EA, Wu D, et al. Tissue and T cell distribution of precursor and mature IL-16. J Immunol. 1998;161:3114.
8. + T cells is activation dependent. J Immunol. 1999; 162:1287.
9. Hessel EM, Cruikshank WW, Van Ark I, et al. Involvement of IL-16 in the induction of airway hyper-responsiveness and up-regulation of IgE in a murine model of allergic asthma. J Immunol. 1998;160:2998.
10. Zhang Y, Center DM, Wu DM, et al. Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem. 1998;273:1144.
11. Cruikshank WW, Long A, Tarpy RE, et al. Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am J Respir Cell Mol Biol. 1995;13: 738.
12. + inflammatory cells: implications for asthma. Am J Respir Crit Care Med. 1994; 150:S59.
13. Laberge S, Ernst P, Ghaffar O, et al. Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma. Am J Respir Cell Mol Biol. 1997;17:193.
14. + T lymphocytes in rheumatoid arthritis. Eur J Immunol. 1998;28:2661.
15. + T cells: potential roles in inflammation. J Immunol. 1997;158:3046.
16. Schluesener HJ, Seid K, Kretzschmar J, Meyermann R. Leukocyte chemotactic factor, a natural ligand to CD4, is expressed by lymphocytes and microglial cells of the MS plaque. J Neurosci Res. 1996;44:606.
17. Baier M, Werner A, Bannert N, Metzner K, Kurth R. HIV suppression by interleukin-16. Nature. 1995;378:563.
18. Maciaszek JW, Parada NA, Cruikshank WW, Center DM, Kornfeld H, Viglianti GA. IL-16 represses HIV-1 promoter activity. J Immunol. 1997;158:5.
19. Scala E, D'Offizi G, Rosso R, et al. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J Immunol. 1997;158:4485.
20. Amiel C, Darcissac E, Truong MJ, et al. Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression. J Infect Dis. 1999;179:83.
21. Issekutz TB, Stoltz JM, Meide PVD. Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma. J Immunol. 1988;140:2989.
22. Larsen CG, Thomsen MK, Gesser B, et al. The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. J Immunol. 1995;155:2151.
23. Rand ML, Warren JS, Mansour MK, Newman W, Ringler DJ. Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1. Am J Pathol. 1996;148: 855.
24. Doyle HA, Murphy JW. MIP-1 alpha contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J Leukoc Biol. 1997;61:147.
25. Bernhagen J, Bacher M, Calandra T, et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med. 1996;183:277.
26. Gautam S, Battisto J, Major JA, Armstrong D, Stoler M, Hamilton TA. Chemokine expression in trinitrochlorobenzene-mediated contact hyper-sensitivity. J Leukoc Biol. 1994;55:452.
27. Devergne O, Marfaing-Koka A, Schall TJ, et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med. 1994;179:1689.
28. Kim YS, Maslinski W, Zheng XX, et al. Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. J Immunol. 1998;160:5742.
29. Li L, Sad S, Kagi D, Mosmann TR. CD8Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J Immunol. 1997;158:4152.
30. Li L, Elliott JF, Mosmann TR. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol. 1994;153:3967.
31. + T cells in response to MIP-1 alpha and MIP-1 beta. Science. 1993;260:355.
32. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med. 1993;177:1821.
33. + T cells is independent of transcription and translation. Evidence for constitutive protein synthesis and storage. J Immunol. 1995;155:2902.
34. + T cells in vitro. J Immunol. 1996;156:310.
35. Lim KG, Wan HC, Bozza PT, et al. Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol. 1996;156:2566.
36. + T lymphocyte chemoattractant factor, IL-16. J Immunol. 1997;159:2904.
37. Kaser A, Dunzendorfer S, Offner FA, et al. A role for IL-16 in the cross-talk between dendritic cells and T cells. J Immunol. 1999;163:3232.
38. Cher DJ, Mosmann TR. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol. 1987;138:3688.
39. + T cells by IL-16 and IL-2. J Immunol. 1998;160:2115.
40. + T cells. Immunology. 1999;96:215.